Literature DB >> 7390779

Avascular necrosis of the femoral head in congenital dislocation of the hip.

H Z Herold.   

Abstract

A study of the X-rays of 450 children treated for congenital dislocation of the hip revealed 56 hips with total or partial avascular necrosis of the femoral head. These hips were classified into four groups. Group 1 consisted of 13 hips in which the femoral head was normal before treatment and avascular necrosis appeared during or after orthopedic or surgical procedures. These are the iatrogenic cases. Group 2 consisted of 22 hips in which avascular necrosis was evident before any treatment. The necrosis was considered a dystrophy arising from malposition. Group 3 included 12 hips in which the avascular necrosis might have been either iatrogenic or a dystrophy due to malposition. This could not be determined because these hips were treated early, before avascular necrosis was seen on X-ray. Group 4 consisted of nine hips in which unilateral dislocation was associated with avascular necrosis of the unaffected normal side prior to any treatment of the affected hip.

Entities:  

Mesh:

Year:  1980        PMID: 7390779

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  3 in total

1.  Radiographic outcome of children older than twenty-four months with developmental dysplasia of the hip treated by closed reduction and spica cast immobilization in human position: a review of fifty-one hips.

Authors:  YiQiang Li; YueMing Guo; XianTao Shen; Hang Liu; HaiBo Mei; HongWen Xu; Federico Canavese
Journal:  Int Orthop       Date:  2019-04-12       Impact factor: 3.075

2.  Closed reduction and dynamic cast immobilization in patients with developmental dysplasia of the hip between 6 and 24 months of age.

Authors:  YiQiang Li; QingHe Zhou; Yuanzhong Liu; WeiDong Chen; JingChun Li; Federico Canavese; HongWen Xu
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-08-03

3.  Proximal femoral growth disturbance in developmental dysplasia of the hip: what do we know?

Authors:  S L Weinstein; L A Dolan
Journal:  J Child Orthop       Date:  2018-08-01       Impact factor: 1.548

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.